Associate ProfessorMD Anderson Cancer CenterHouston, Texas, United States
Disclosure information not submitted.
LB802 - Results Of ctDNA As A Predictive Biomarker In Adjuvant Chemotherapy In Stage II Colon Cancer: NRG-GI005 (COBRA) Phase II/III study
Monday, June 3, 20243:55 PM – 4:01 PM ET, USA